ArticleRheumatology (Oxford, England)2025

Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases.

Amy Fuller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.